Mayo Clinic Laboratory and Pathology Research Roundup: March 25

By Alyssa Frank • March 25, 2019

Share this:

The Research Roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Featured Abstract

High-Sensitivity Cardiac Troponin after Cardiac Stress Test: A Systematic Review and Meta-Analysis

The recent introduction of high-sensitivity cardiac troponin (hs-cTn) assays has allowed clinicians to measure hs-cTn before and after cardiac stress testing, but the hs-cTn release pattern and potential utility in identifying inducible myocardial ischemia are unclear. The authors conducted a systematic review and meta-analysis to improve our understanding of hs-cTn release associated with exercise and pharmacological stress testing.

Published to PubMed This Week

• • • • • Long-Term Mortality after Revision THA
          Clinical Orthopaedics and Related Research
        • Prediction of Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score (NAS) with Multiparametric Hepatic Magnetic Resonance Imaging and Elastography
          European Radiology
          
        • Temporal Trends and Outcomes of Prolonged Invasive Mechanical Ventilation and Tracheostomy Use in Acute Myocardial Infarction with Cardiogenic Shock in the United States
          International Journal of Cardiology
        • Cardiovascular Morbidity and Mortality after Aortic Dissection, Intramural Hematoma, and Penetrating Aortic Ulcer
          Journal of Vascular Surgery
        • Factor V Deficiency with a Thrombotic Clinical Phenotype
          Seminars in Thrombosis and Hemostasis
        • Unidentified Anion Gap Metabolic Acidosis
          Clinical Biochemistry
        • Catecholamine and Metanephrine Levels in Breast Milk Before and After Paraganglioma Resection
          Breastfeeding Medicine
        • Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas
          Frontiers in Oncology
          
        • Identification of High-Risk DUSP22-Rearranged ALK-Negative Anaplastic Large Cell Lymphoma
          British Journal of Haematology

Alyssa Frank

Alyssa Frank is a Marketing Segment Manager at Mayo Clinic Laboratories. She leads marketing strategies for product management and specialty testing. Alyssa has worked at Mayo Clinic since 2015.